Editas Medicine Aktie
WKN DE: A2AC4K / ISIN: US28106W1036
13.08.2025 19:03:10
|
Editas Medicine Shares Soar 35% On Synthetic Biology Market Growth Outlook
(RTTNews) - Editas Medicine, Inc. (EDIT) jumped 35.15 percent to $3.09, rising $0.80 on Wednesday, after Custom Market Insights released a report projecting strong growth in the synthetic biology market.
The stock opened at $2.45 and traded between $2.44 and $3.10, with 4.68 million shares changing hands compared to an average of 2.46 million on the Nasdaq. Editas Medicine's 52-week range is $0.91 to $4.19.
Industry experts highlighted increasing demand for sustainable solutions such as biofuels, biodegradable plastics, and eco-friendly chemicals, alongside advances in gene editing and biotechnology that could drive innovation in healthcare, agriculture, and industrial applications.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Editas Medicine Incmehr Nachrichten
11.05.25 |
Ausblick: Editas Medicine verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net) |
Analysen zu Editas Medicine Incmehr Analysen
Aktien in diesem Artikel
Editas Medicine Inc | 3,26 | 10,95% |
|